NACHT MARIUS 13D and 13G filings for BiondVax Pharmaceuticals Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-27 09:04 am Purchase |
2022-12-20 | 13D | BiondVax Pharmaceuticals Ltd. BVXV |
NACHT MARIUS | 170,961,770 12.300% |
153,865,593 (+900.00%) |
Filing |
| 2022-01-11 12:47 pm Unchanged |
2021-12-29 | 13D | BiondVax Pharmaceuticals Ltd. BVXV |
NACHT MARIUS | 17,096,177 23.600% |
0 (Unchanged) |
Filing |
| 2021-02-09 06:01 am Purchase |
2021-02-02 | 13D | BiondVax Pharmaceuticals Ltd. BVXV |
NACHT MARIUS | 17,096,177 30.600% |
11,720,094 (+218.00%) |
Filing |